Biocryst Pharmaceuticals Inc: which funds bought and sold
Institutions that bought and sold Biocryst Pharmaceuticals shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 187 institutions that filed 13F reports for both quarters added to or opened positions in Biocryst Pharmaceuticals, and 121 cut or closed them. Together they added a net 14.1M shares, +5.9% on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 9.9M shares (+12.6%); index fund managers were net buyers of 5.0M shares (+7.1%). 53 opened a new position and 35 sold out entirely.
Bought, Q2 2026 187 institutions, 53 of them new holders Sold, Q2 2026 121 institutions, 35 of them sold out
Net change, all compared +14.1M shares (+5.9%)
Net change, active managers +9.9M shares (+12.6%), 36 bought, 25 sold
Buyers versus sellers
187 bought 42 121 sold
Active managers and hedge funds 36 bought · 25 sold · +9.9M
Index fund managers 8 bought · 4 sold · +5.0M
Other institutions 143 bought · 92 sold · −737K
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Millennium Management LLC Hedge fund | +3.2M +1708.4% | 3.4M | $33.9M |
| State Street Corp Index funds | +3.0M +24.4% | 15.2M | $152M |
| Perceptive Advisors LLC Hedge fund | +2.9M +38.7% | 10.3M | $103M |
| Jane Street Group, LLC | +2.1M +343.7% | 2.8M | $27.6M |
| Goldman Sachs Group Inc | +2.1M +90.9% | 4.5M | $44.8M |
| Nantahala Capital Management, LLC Hedge fund | +1.8M +91.3% | 3.8M | $38M |
| AQR Capital Management LLC Hedge fund | +1.8M +403.1% | 2.2M | $22.1M |
| Renaissance Technologies LLC Hedge fund | +1.8M +225.7% | 2.5M | $25.3M |
| Vestal Point Capital, LP Hedge fund | +1.3M +18.1% | 8.3M | $83M |
| Blackrock, Inc. Index funds | +1.2M +5.5% | 23.9M | $239M |
| HRT Financial LP | +1.1M New position | 1.1M | $10.8M |
| Imc-Chicago, LLC | +1.0M +158.9% | 1.6M | $16.3M |
| Moore Capital Management, LP Hedge fund | +848K New position | 848K | $8.5M |
| Pictet Asset Management Holding SA | +778K +165.0% | 1.2M | $12M |
| Citadel Advisors LLC Hedge fund | +740K +72.7% | 1.8M | $17.6M |
| Healthcare Of Ontario Pension Plan Trust Fund | +618K +50.4% | 1.8M | $18.4M |
| Exoduspoint Capital Management, LP Hedge fund | +555K +291.9% | 745K | $7.4M |
| Assenagon Asset Management S.A. | +473K +203.1% | 706K | $7.1M |
| Geode Capital Management, LLC Index funds | +465K +8.0% | 6.2M | $62.5M |
| Jump Financial, LLC | +461K +420.9% | 570K | $5.7M |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Millennium Management LLC Hedge fund | +3.2M +1708.4% | 3.4M | $33.9M |
| Perceptive Advisors LLC Hedge fund | +2.9M +38.7% | 10.3M | $103M |
| Nantahala Capital Management, LLC Hedge fund | +1.8M +91.3% | 3.8M | $38M |
| AQR Capital Management LLC Hedge fund | +1.8M +403.1% | 2.2M | $22.1M |
| Renaissance Technologies LLC Hedge fund | +1.8M +225.7% | 2.5M | $25.3M |
| Vestal Point Capital, LP Hedge fund | +1.3M +18.1% | 8.3M | $83M |
| Moore Capital Management, LP Hedge fund | +848K New position | 848K | $8.5M |
| Citadel Advisors LLC Hedge fund | +740K +72.7% | 1.8M | $17.6M |
| Exoduspoint Capital Management, LP Hedge fund | +555K +291.9% | 745K | $7.4M |
| Jupiter Asset Management Ltd Active manager | +447K +37.3% | 1.6M | $16.4M |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Royalty Pharma Sub-Manager, LLC | −3.8M Sold out | 0 | — |
| Kynam Capital Management, LP Hedge fund | −3.2M −55.6% | 2.5M | $25.2M |
| Rfg Advisory, LLC | −2.9M Sold out | 0 | — |
| Susquehanna International Group, LLP | −1.6M −57.5% | 1.2M | $12M |
| Pacer Advisors, Inc. | −1.6M −99.7% | 4,436 | $44,000 |
| Eversept Partners, LP Hedge fund | −1.2M −38.6% | 1.9M | $18.7M |
| Jpmorgan Chase & Co | −1.0M −65.9% | 525K | $5.1M |
| Jacobs Levy Equity Management, Inc Active manager | −1.0M Sold out | 0 | — |
| Hillsdale Investment Management Inc. | −639K Sold out | 0 | — |
| Schonfeld Strategic Advisors LLC Hedge fund | −627K −46.9% | 711K | $7.1M |
| Man Group PLC Hedge fund | −560K −43.3% | 733K | $7.3M |
| PDT Partners, LLC Hedge fund | −539K −95.7% | 24K | $244,890 |
| Elmind Capital, LP | −480K −48.0% | 520K | $5.2M |
| Sphera Funds Management Ltd. | −444K −51.3% | 422K | $4.2M |
| Federated Hermes, Inc. Active manager | −299K −97.6% | 7,296 | $72,960 |
| Bank Of America Corp | −290K −5.7% | 4.8M | $48M |
| Deutsche Bank Ag\ | −258K −31.4% | 563K | $5.6M |
| Capricorn Fund Managers Ltd | −203K Sold out | 0 | — |
| Rosalind Advisors, Inc. | −202K −21.8% | 722K | $7.2M |
| Russell Investments Group, Ltd. | −197K −72.5% | 75K | $746,990 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Kynam Capital Management, LP Hedge fund | −3.2M −55.6% | 2.5M | $25.2M |
| Eversept Partners, LP Hedge fund | −1.2M −38.6% | 1.9M | $18.7M |
| Jacobs Levy Equity Management, Inc Active manager | −1.0M Sold out | 0 | — |
| Schonfeld Strategic Advisors LLC Hedge fund | −627K −46.9% | 711K | $7.1M |
| Man Group PLC Hedge fund | −560K −43.3% | 733K | $7.3M |
| PDT Partners, LLC Hedge fund | −539K −95.7% | 24K | $244,890 |
| Federated Hermes, Inc. Active manager | −299K −97.6% | 7,296 | $72,960 |
| Balyasny Asset Management L.P. Hedge fund | −186K Sold out | 0 | — |
| Gotham Asset Management, LLC Hedge fund | −157K −50.0% | 156K | $1.6M |
| Bridgewater Associates, LP Hedge fund | −147K −23.0% | 491K | $4.9M |
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| HRT Financial LP | 1.1M | $10.8M |
| Moore Capital Management, LPHedge fund | 848K | $8.5M |
| Nan Fung Trinity (HK) Ltd | 450K | $4.5M |
| Wedge Capital Management L L PActive manager | 381K | $3.8M |
| Aquatic Capital Management LLC | 363K | $3.6M |
| Nfj Investment Group, LLC | 279K | $2.8M |
| Point72 Asset Management, L.P.Hedge fund | 261K | $2.6M |
| Ieq Capital, LLC | 227K | $2.3M |
| Hussman Strategic Advisors, Inc. | 210K | $2.1M |
| Pfm Health Sciences, LPHedge fund | 207K | $2.1M |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| Royalty Pharma Sub-Manager, LLC | 3.8M | $36.6M |
| Rfg Advisory, LLC | 2.9M | $27.3M |
| Jacobs Levy Equity Management, IncActive manager | 1.0M | $9.6M |
| Hillsdale Investment Management Inc. | 639K | $6.1M |
| Capricorn Fund Managers Ltd | 203K | $1.9M |
| Balyasny Asset Management L.P.Hedge fund | 186K | $1.8M |
| University Of Texas/Texas Am Investment Management Co | 91K | $866,101 |
| Panagora Asset Management IncActive manager | 89K | $846,100 |
| Dark Forest Capital Management LP | 78K | $743,541 |
| Entropy Technologies, LP | 76K | $722,644 |
Who holds the shares
- Institutions reporting
- 318
- Ten largest holders
- 49.9% of 13F-reported shares
- Index fund managers
- 28.4% of 13F-reported shares
- Active managers and hedge funds
- 33.5% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 36 | 25 | 11 | 6 | +9.9M | +12.6% |
| Index fund managers | 8 | 4 | 0 | 0 | +5.0M | +7.1% |
| Other institutions | 143 | 92 | 42 | 29 | −737K | −0.8% |
← Back to Biocryst Pharmaceuticals Inc · Insiders · Politicians